ClinVar Miner

Submissions for variant NM_000038.6(APC):c.3593C>G (p.Ser1198Ter)

dbSNP: rs879254089
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000236148 SCV000293417 pathogenic not provided 2015-12-22 criteria provided, single submitter clinical testing This variant is denoted APC c.3593C>G at the cDNA level and p.Ser1198Ter (S1198X) at the protein level. The substitution creates a nonsense variant, which changes a Serine to a premature stop codon (TCA>TGA) , and is predicted to cause loss of normal protein function through protein truncation. APC Ser1198Ter results in the loss of 1646 amino acids and several protein domains are disrupted by the truncation (Azzopardi 2008, UniProt). This variant has been reported in association with familial adenomatous polyposis (Wallis 1994, Friedl 2005) and is considered pathogenic.
Invitae RCV003535656 SCV003439216 pathogenic Familial adenomatous polyposis 1 2023-01-20 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. A different truncation (p.Tyr2645Lysfs*14) that lies downstream of this variant has been determined to be pathogenic (PMID: 9824584, 1316610, 27081525, 8381579, 22135120, Invitae). This suggests that deletion of this region of the APC protein is causative of disease. This variant is expected to disrupt the EB1 and HDLG binding sites, which mediate interactions with the cytoskeleton (PMID: 15311282, 17293347). While functional studies have not been performed to directly test the effect on APC protein function, this suggests that disruption of the C-terminal portion of the protein is functionally important. ClinVar contains an entry for this variant (Variation ID: 246086). This premature translational stop signal has been observed in individual(s) with clinical features of familial adenomatous polyposis (PMID: 7959691, 27623068). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser1198*) in the APC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1646 amino acid(s) of the APC protein.
Myriad Genetics, Inc. RCV002519827 SCV004044683 pathogenic Familial adenomatous polyposis 1 2023-05-09 criteria provided, single submitter clinical testing This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.